ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 3:59 PM
0.64
0.59%
After-hours: Aug 15, 2025, 05:02 PM EDT
ALX Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 868K | 868K | 868K | 2.48M | 2.48M | 2.48M | 2.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.18 | 1.18 | 527K |
Cost of Revenue | 626K | 655K | 658K | 865K | 850K | 1.14M | 1.45M | 1.65M | 1.44M | 1.21M | 1.07M | 915K | 1.18M | 1.05M | 678K | 419K | 157K | 484K |
Gross Profit | -192K | -221K | -224K | -865K | -850K | -1.14M | -1.45M | -1.65M | -1.44M | -1.21M | -1.07M | -915K | -1.18M | -1.05M | -678K | -419K | -157K | 43K |
Operating Income | -121.65M | -136.53M | -142.47M | -159.88M | -180.59M | -175.84M | -170.28M | -154.47M | -137.88M | -134.89M | -127.44M | -123.69M | -111.58M | -94.09M | -83.56M | -72.91M | -58.14M | -52.63M |
Interest Income | 6.77M | 8.23M | 9.37M | 10.48M | 10.86M | 10.96M | 10.65M | 9.46M | 8.15M | 6.36M | 4.28M | 2.47M | 1.12M | 270K | 70K | 70K | 48K | 25K |
Pretax Income | -116.57M | -130.02M | -134.85M | -151.16M | -171.44M | -166.2M | -160.81M | -145.98M | -130.31M | -129.07M | -123.42M | -121.23M | -110.48M | -93.83M | -83.48M | -73.62M | -59.2M | -54.23M |
Net Income | -116.57M | -130.02M | -134.85M | -151.16M | -171.44M | -166.2M | -159.17M | -144.41M | -128.74M | -126.63M | -122.4M | -120.13M | -109.37M | -93.6M | -83.46M | -73.8M | -59.41M | -54.47M |
Selling & General & Admin | 26.56M | 27.76M | 25.66M | 24.61M | 26.02M | 26.67M | 28.28M | 29.27M | 29.06M | 28.8M | 29.04M | 29.59M | 28.66M | 26.7M | 23.39M | 21.49M | 19.61M | 17.7M |
Research & Development | 91.91M | 108.54M | 116.37M | 134.63M | 153.92M | 148.75M | 141.79M | 125.21M | 108.82M | 106.09M | 98.4M | 94.1M | 82.93M | 67.39M | 60.17M | 51.42M | 38.53M | 34.98M |
Other Expenses | -191K | n/a | n/a | n/a | n/a | 324K | 419K | 186K | 177K | -154K | -260K | -11K | 12K | 47K | 84K | 73K | 59K | 31K |
Operating Expenses | 118.28M | 136.31M | 142.03M | 159.24M | 179.94M | 175.42M | 170.07M | 154.47M | 137.88M | 134.89M | 127.44M | 123.69M | 111.58M | 94.09M | 83.56M | 72.91M | 58.14M | 52.68M |
Interest Expense | 1.68M | 1.71M | 1.73M | 1.72M | 1.66M | 1.6M | 1.56M | 1.15M | 761K | 391K | 7K | 10K | 12K | 13K | 13K | 161K | 383K | 599K |
Selling & Marketing Expenses | n/a | -220K | -434K | -641K | -641K | -421K | -207K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 118.47M | 136.53M | 142.47M | 159.88M | 180.59M | 175.84M | 170.28M | 154.47M | 137.88M | 134.89M | 127.44M | 123.69M | 111.58M | 94.09M | 83.56M | 72.91M | 58.14M | 53.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | -209K | -209K | -1.84M | -1.78M | -1.57M | -2.44M | -1.02M | -1.1M | -1.09M | -186K | 57K | 260K | 277K | 266K |
Shares Outstanding (Basic) | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
Shares Outstanding (Diluted) | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
EPS (Basic) | -2.2 | -2.47 | -2.6 | -2.98 | -3.64 | -3.72 | -3.71 | -3.53 | -3.16 | -3.11 | -3.01 | -2.96 | -2.7 | -2.31 | -2.06 | -1.86 | -1.59 | -1.52 |
EPS (Diluted) | -2.2 | -2.47 | -2.6 | -2.98 | -3.64 | -3.72 | -3.71 | -3.53 | -3.16 | -3.11 | -3.01 | -2.96 | -2.7 | -2.31 | -2.06 | -1.86 | -1.59 | -1.52 |
EBITDA | -115.34M | -127.45M | -132.25M | -148.58M | -168.93M | -163.45M | -157.79M | -145.06M | -129.59M | -128.96M | -123.83M | -120.14M | -109.78M | -93.4M | -83.45M | -73.46M | -58.82M | -53.57M |
EBIT | -114.89M | -128.31M | -133.12M | -149.44M | -169.78M | -164.6M | -159.24M | -146.4M | -131.12M | -130.25M | -124.98M | -121.22M | -110.48M | -93.86M | -83.54M | -73.52M | -58.87M | -53.66M |
Depreciation & Amortization | 840K | 869K | 872K | 865K | 850K | 1.14M | 1.45M | 1.65M | 1.54M | 1.31M | 1.16M | 1.01M | 1.18M | 1.05M | 678K | 424K | 167K | 94K |